PROM1 and malignant colon neoplasm: This might be due to higher CXCR4 expression in rectal cancer than in colon cancer[20], suggesting that the percentage of CD133+CXCR4+ cancer cells in future studies should be investigated separately in colon and rectal cancer rather than in a mixed way.